Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Other financing activities: 2023

Historic Other financing activities for Crinetics Pharmaceuticals (CRNX) over the last 1 years, with Dec 2023 value amounting to $26,000.

  • Crinetics Pharmaceuticals' Other financing activities fell 3617.72% to -$15.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$11.5 million, marking a year-over-year change of. This contributed to the annual value of $26,000 for FY2023, which is N/A change from last year.
  • Crinetics Pharmaceuticals' Other financing activities amounted to $26,000 in FY2023.
  • Crinetics Pharmaceuticals' 5-year Other financing activities high stood at $26,000 for FY2023, and its period low was $26,000 during FY2023.
  • In the last 1 years, Crinetics Pharmaceuticals' Other financing activities had a median value of $26,000 in 2023 and averaged $26,000.